Relmada Therapeutics's three largest insider shareholders as of August 29, 2026 are Sergio Traversa (Chief Executive Officer, 1.30Mn shares), Maged Shenouda (Chief Financial Officer, 800.00K shares), Paul Edward Kelly (Chief Operating Officer, 502.30K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Sergio Traversa | Chief Executive Officer | 1,300,000 | 0 | 1,300,000 | 43.1% | 16 Dec, 2025 |
| 2 | Maged Shenouda | Chief Financial Officer | 800,000 | 0 | 800,000 | 26.5% | 16 Dec, 2025 |
| 3 | Paul Edward Kelly | Chief Operating Officer | 502,295 | 0 | 502,295 | 16.7% | 06 Nov, 2025 |
| 4 | Chuck Ence | Cao And Coo | 403,931 | 0 | 403,931 | 13.4% | 06 Nov, 2025 |
| 5 | Cedric O'Gorman | Chief Medical Officer | 10,121 | 0 | 10,121 | 0.3% | 24 May, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 12 Dec, 2025 | Fabiana Fedeli | Director | Acquired A | 164,000 | $0.00 | $0 | 164,000 | Direct |
| 12 Dec, 2025 | Paul Edward Kelly | Coo | Acquired A | 828,000 | $0.00 | $0 | 828,000 | Direct |
| 15 Dec, 2025 | Maged Shenouda | Chief Financial Officer | Acquired P | 11,665 | $4.12 | $48.06K | 800,000 | Direct |
| 12 Dec, 2025 | Charles J Casamento | Director | Acquired A | 164,000 | $0.00 | $0 | 164,000 | Direct |
| 15 Dec, 2025 | Maged Shenouda | Chief Financial Officer | Acquired P | 11,665 | $4.12 | $48.06K | 800,000 | Direct |
| 15 Dec, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 27,500 | $4.12 | $113.30K | 1,300,000 | Direct |
| 12 Dec, 2025 | Chuck Ence | Ca And Co | Acquired A | 828,000 | $0.00 | $0 | 828,000 | Direct |
| 15 Dec, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 27,500 | $4.12 | $113.30K | 1,300,000 | Direct |
| 15 Dec, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 27,500 | $4.12 | $113.30K | 1,300,000 | Direct |
| 12 Dec, 2025 | John Glasspool | Director | Acquired A | 164,000 | $0.00 | $0 | 164,000 | Direct |
| 15 Dec, 2025 | Maged Shenouda | Chief Financial Officer | Acquired P | 11,665 | $4.12 | $48.06K | 800,000 | Direct |
| 12 Dec, 2025 | Maged Shenouda | Chief Financial Officer | Acquired A | 828,000 | $0.00 | $0 | 828,000 | Direct |
| 12 Dec, 2025 | Sergio Traversa | Chief Executive Officer | Acquired A | 1,198,000 | $0.00 | $0 | 1,198,000 | Direct |
| 12 Dec, 2025 | Sergio Traversa | Chief Executive Officer | Acquired A | 1,198,000 | $0.00 | $0 | 1,198,000 | Direct |
| 12 Dec, 2025 | Maged Shenouda | Chief Financial Officer | Acquired A | 828,000 | $0.00 | $0 | 828,000 | Direct |
| 12 Dec, 2025 | Maged Shenouda | Chief Financial Officer | Acquired A | 828,000 | $0.00 | $0 | 828,000 | Direct |
| 12 Dec, 2025 | Sergio Traversa | Chief Executive Officer | Acquired A | 1,198,000 | $0.00 | $0 | 1,198,000 | Direct |
| 05 Nov, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 272,500 | $2.20 | $599.50K | 1,272,500 | Direct |
| 05 Nov, 2025 | Sergio Traversa | Chief Executive Officer | Acquired P | 272,500 | $2.20 | $599.50K | 1,272,500 | Direct |
| 05 Nov, 2025 | Maged Shenouda | Chief Financial Officer | Acquired P | 500,000 | $2.20 | $1.10Mn | 788,335 | Direct |